title: Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al.
authors: Pediatric Oncology Unit, Istituto Nazionale Tumori, Università degli Studi di Milano, Via Venezian 1, 20133, Milan, Italy, maura.massimino@istitutotumori.mi.it.
authors: Maura
authors: M
authors: Massimino
authors: Carlo Alfredo
authors: CA
authors: Clerici
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D044482:Benzeneacetamides / Q000009:adverse effects / Q000627:therapeutic use*; D035843:Biomedical Research / Q000592:standards; D020295:Brain Stem Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D004338:Drug Combinations; D005260:Female; D005910:Glioma / Q000188:drug therapy* / Q000401:mortality; D005973:Glutamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality; D010648:Phenylacetates / Q000009:adverse effects / Q000627:therapeutic use*; D010881:Piperidones / Q000009:adverse effects / Q000627:therapeutic use*; D011149:Pons; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D044482:Benzeneacetamides; D004338:Drug Combinations; D010648:Phenylacetates; D010881:Piperidones; D005973:Glutamine; C092038:antineoplaston AS 2-1; C052091:antineoplaston A10